Abiomed Value Stock - Dividend - Research Selection
Market price: 238,65 USD
Abiomed Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||274.578.000|
|Free cash flow||221.195.008|
|Liabilities & Shareholders equity||1.673.390.000|
|Diluted shares outstanding||45.674.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||10.900.100.096,00 USD|
|Indices||NASDAQ Comp.,Russell 3000,S&P 500,MSCI World Index|
|Sectors||Health Care Equipment|
|Raw Data Source||US GAAP in Millionen USD|
|Stock Split||2000-10-03,2.0000/1.0000; 2000-10-02,2.0000/1.0000|
Description of the company
ABIOMED, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. In September 2012, the Company announced that its Impella CP product received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for partial circulatory support for up to six hours.